Risk aversion and COVID‐19 vaccine hesitancy
Anthony Lepinteur,
Liyousew Borga,
Andrew Clark,
Claus Vögele and
Conchita D’Ambrosio
Health Economics, 2023, vol. 32, issue 8, 1659-1669
Abstract:
We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://doi.org/10.1002/hec.4693
Related works:
Working Paper: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk Aversion and COVID-19 Vaccine Hesitancy (2023) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:32:y:2023:i:8:p:1659-1669
Access Statistics for this article
Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones
More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().